Back to search
A Phase 1 Study, in Cystic Fibrosis Patients, of the Safety, Toxicity, and Biological Efficacy of a Single Administration of a Replication Deficient, Recombinant Adenovirus Carrying the cDNA of the Normal Cystic Fibrosis Transmembrane Conductance Regulator Gene in the Lung. National Institutes of Health, Bethesda, Maryland
Data up to Jan 2025
Published1995
Citations68
References0
Total Citations Per Year
Abstract
References (0)
No references found
Cited By (0)
Loading...